XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Cumulative Distributions in Excess of Earnings
Beginning balance (in shares) at Dec. 31, 2021   96,296,673    
Beginning balance at Dec. 31, 2021 $ 915,757 $ 963 $ 1,196,839 $ (282,045)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted common stock, net of shares withheld for employee taxes (in shares)   190,393    
Vesting of restricted common stock, net of shares withheld for employee taxes (2,772) $ 2 (2,774)  
Amortization of stock-based compensation 1,521   1,521  
Common dividends (26,659)     (26,659)
Net income (loss) (43,264)     (43,264)
Ending balance (in shares) at Mar. 31, 2022   96,487,066    
Ending balance at Mar. 31, 2022 844,583 $ 965 1,195,586 (351,968)
Beginning balance (in shares) at Dec. 31, 2021   96,296,673    
Beginning balance at Dec. 31, 2021 915,757 $ 963 1,196,839 (282,045)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (22,595)      
Ending balance (in shares) at Jun. 30, 2022   96,605,112    
Ending balance at Jun. 30, 2022 838,268 $ 966 1,195,282 (357,980)
Beginning balance (in shares) at Mar. 31, 2022   96,487,066    
Beginning balance at Mar. 31, 2022 844,583 $ 965 1,195,586 (351,968)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted common stock, net of shares withheld for employee taxes (in shares)   118,046    
Vesting of restricted common stock, net of shares withheld for employee taxes (1,697) $ 1 (1,698)  
Amortization of stock-based compensation 1,394   1,394  
Common dividends (26,681)     (26,681)
Net income (loss) 20,669     20,669
Ending balance (in shares) at Jun. 30, 2022   96,605,112    
Ending balance at Jun. 30, 2022 $ 838,268 $ 966 1,195,282 (357,980)
Beginning balance (in shares) at Dec. 31, 2022 99,010,112 99,010,112    
Beginning balance at Dec. 31, 2022 $ 849,373 $ 990 1,245,337 (396,954)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted common stock, net of shares withheld for employee taxes (in shares)   87,978    
Vesting of restricted common stock, net of shares withheld for employee taxes (1,479) $ 1 (1,480)  
Amortization of stock-based compensation 936   936  
Common dividends (27,738)     (27,738)
Net income (loss) 19,227     19,227
Ending balance (in shares) at Mar. 31, 2023   99,098,090    
Ending balance at Mar. 31, 2023 $ 840,319 $ 991 1,244,793 (405,465)
Beginning balance (in shares) at Dec. 31, 2022 99,010,112 99,010,112    
Beginning balance at Dec. 31, 2022 $ 849,373 $ 990 1,245,337 (396,954)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) $ 18,743      
Ending balance (in shares) at Jun. 30, 2023 99,124,082 99,124,082    
Ending balance at Jun. 30, 2023 $ 813,022 $ 991 1,245,717 (433,686)
Beginning balance (in shares) at Mar. 31, 2023   99,098,090    
Beginning balance at Mar. 31, 2023 840,319 $ 991 1,244,793 (405,465)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted common stock (in shares)   25,992    
Amortization of stock-based compensation 924   924  
Common dividends (27,737)     (27,737)
Net income (loss) $ (484)     (484)
Ending balance (in shares) at Jun. 30, 2023 99,124,082 99,124,082    
Ending balance at Jun. 30, 2023 $ 813,022 $ 991 $ 1,245,717 $ (433,686)